In addition, plasma GDF3 levels were gradually elevated with the NAFLD activity score (NAS) (Fig. 3e) and with the scores of steatosis and ballooning, as well as the degree of lobular inflammation (Fig. 3f−h). This evidence concerns the gene GDF3 and metabolic dysfunction-associated steatotic liver disease.